Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on July 31st, 2023%
A system using deep learning algorithms to analyze ultrasound video images is shown to detect a difficult-to diagnose type of heart failure with clips from one view of the heart. . . . → Read More: A.I. Analytics Detect Heart Failure in Single Ultrasound View
By Alan, on July 27th, 2023%
A group of academic and industry researchers exhibited in lab cells and mice a more direct delivery technique that could make gene therapies more accessible and inexpensive. . . . → Read More: Streamlined Gene Therapy Delivery Process Demonstrated
By Alan, on July 26th, 2023%
A treatment for depression designed as a game for patients will be assessed in a clinical trial conducted by a university psychology lab and funded by National Institutes of Health. . . . → Read More: NIH Funds Depression Game Therapy Clinical Trial
By Alan, on July 25th, 2023%
A biotechnology company creating living tissue from a person’s stem cells says it received FDA clearance for a clinical trial of its replacement knee cartilage. . . . → Read More: Trial Cleared for Lab-Grown Replacement Knee Cartilage
By Alan, on July 20th, 2023%
A treatment for HIV taken just once, using the genome-editing technology Crispr, is receiving fast-track designation from the U.S. Food and Drug Administration. . . . → Read More: One-Time Crispr HIV Therapy Given Fast-Track Status
By Alan, on July 19th, 2023%
A synthetic biology company is receiving a contract with the U.S. advanced defense research agency to devise a high-speed localized process for making therapeutic proteins. . . . → Read More: Darpa Seeking On-Demand, Distributed Production of Proteins
By Alan, on July 17th, 2023%
A biopharmaceutical company and university neuroscience lab are collaborating on a clinical trial testing a peptide nasal spray treatment for social anxiety disorder. . . . → Read More: Drug Maker, Univ. Lab Partner on Neuropeptide Anxiety Trial
By Alan, on July 13th, 2023%
A new venture fund says it’s investing in health and life science start-ups implementing advanced technologies, particularly artificial intelligence, that promise to transform the field. . . . → Read More: Venture Fund to Back Life Science A.I. Start-Ups
By Alan, on July 5th, 2023%
A lab-on-a-chip device with human organ cells is shown in lab tests to distinguish between malaria strains and detect drug toxicity when assessing blood for seven days. . . . → Read More: Biochip Device Tests Malaria Drug Efficacy, Safety
By Alan, on June 23rd, 2023%
A company creating a network of long-range high-altitude balloons to expand the scope of global weather forecasting is raising $6 million in seed funds. . . . → Read More: Weather Balloon Data Company Raises $6M in Seed Funds
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|